key: cord-0824723-rqlwwwz5
authors: Al-Rawi, Natheer H; Sammouda, Ayat R; AlRahin, Eman A; Ali, Fatma A Al; Arayedh, Ghadeer S Al; Daryanavard, Hamideh A; Saeed, Musab H; Nuaimi, Ahmed S Al
title: Prevalence of Anosmia or Ageusia in COVID-19 Patients Among UAE Population
date: 2021-05-24
journal: Int Dent J
DOI: 10.1016/j.identj.2021.05.006
sha: 35be399cd277ae97778657a3589916a7bc0a499c
doc_id: 824723
cord_uid: rqlwwwz5

OBJECTIVE: To determine the relationship and prevalence of taste and smell dysfunction in patients with COVID-19 in the UAE population. METHODS: Enrolled participants were interviewed online via a phone call after obtaining their informed consent. Quantification of smell, taste, and other sensations before, during, and after COVID-19 infection was correlated with the severity of COVID-19 symptoms. RESULTS: A total of 500 (mild – severe) COVID-19 patients completed the survey. A total of 26.4% were asymptomatic, and 21.4% were classified as paucisymptomatic with less severe symptoms. Almost equal proportions of the studied population experienced extreme taste sensation reductions (43%) and loss of smell sensation (44%). Statistically significant drastic decreases in smell and taste senses were seen among younger ages. The magnitude of reduction in both sense changes increased steeply from the asymptomatic group to the paucisymptomatic group to the symptomatic group. CONCLUSION: Sudden anosmia or ageusia needs to be recognized for early detection of COVID-19 infection to identify otherwise hidden carriers, thus favoring an early isolation strategy that will restrict the spread of the disease.

Objective To determine the relationship and prevalence of taste and smell dysfunction in patients with COVID-19 in the UAE population.

Methods Enrolled participants were interviewed online via a phone call after obtaining their informed consent. Quantification of smell, taste, and other sensations before, during, and after COVID-19 infection was correlated with the severity of COVID-19 symptoms.

Results A total of 500 (mild -severe) COVID-19 patients completed the survey. A total of 26.4% were asymptomatic, and 21.4% were classified as paucisymptomatic with less severe symptoms. Almost equal proportions of the studied population experienced extreme taste sensation reductions (43%) and loss of smell sensation (44%). Statistically significant drastic decreases in smell and taste senses were seen among younger ages. The magnitude of reduction in both sense changes increased steeply from the asymptomatic group to the paucisymptomatic group to the symptomatic group.

Conclusion Sudden anosmia or ageusia needs to be recognized for early detection of COVID-19 infection to identify otherwise hidden carriers, thus favoring an early isolation strategy that will restrict the spread of the disease.

Evidence has demonstrated that an abrupt lack of smell and taste has been observed even in the absence of usual general symptoms of COVID-19. This may act as another gateway to the early spotting of patients with COVID-19. (1) (2) (3) The exact mechanism that causes COVID-19 patients to undergo such a manifestation is still not clear. Zhou In view of these results, the correlation of anosmia and/or ageusia to the early detection of COVID-19-infected cases could identify otherwise hidden carriers, thus favoring an early isolation strategy that will restrict the spread of the disease. Therefore, the purpose of this study was to determine the relationship and prevalence of taste and smell dysfunction in patients with 3 COVID-19 in the UAE population.

This cross-sectional observational study was conducted in Dubai with the approval of the Dubai Research Ethics Committee (DSREC-08/2020 31). Patients diagnosed with COVID-19, in private and governmental clinics and hospitals report to Dubai Health Authority (DHA), which is the healthcare governmental entity responsible in Dubai, all the cases recruited in this study were from the DHA records, thus the study sample was from all governmental and private clinics and hospital in Dubai. Cases based on clinical features and confirmed by a real-time polymerase chain reaction (RT-PCR) test using a nasopharyngeal swab were recruited from 28 August to 11 September 2020.

The study involved patients who were home-isolated, hotel-isolated, or hospitalized during the active period of the disease. A total of 880 participants were approached during the data collection process to fill out the questionnaire. Patients excluded were those under 18 years old, as they require the presence of a guardian and might not answer accurately, patients under ventilation, those with a previous history of dementia or taste and smell dysfunction, patients who did not answer, those who refused to participate, patients with a language barrier, and those who did not provide clear answers. Therefore, the overall number of participants in this study that matched the exclusion and inclusion criteria was 500 participants. The patients' consent was obtained by uploading the consent form via an online application and requesting a reply with their approval.

The questionnaire used in this study was obtained from the Global Consortium of Chemosensory Research (GCCR) (https://gcchemosensr.org/) in both Arabic and English versions with some applied modifications to assess both quantitative and qualitative changes in smell, taste, and other sensations in the mouth (for example, burning, tingling, cooling) before, during, and after the active period of the disease. (1) To assess the personal perception of nasal block severity, smell intensity, taste sensation, and the ability to feel other sensations in the mouth (such as burning, cooling, or tingling), a visual analog scale with a score varying from 1 to 10, where a score of 1 is the minimum and a score of 10 is the maximum, was used. The personal perception of the mentioned sensations was recorded at three different durations, the first as a baseline right before COVID-19, the second was during the illness, and the last was recorded after recovery. To measure the changes at each time point, the score at the given time point was subtracted from the comparison time frame. A negative sign of the resulting change score reflects a reduction in sensation, while a positive sign reflects an increase in magnitude for that specific sense. These changes in the scores were grouped into five categories. Scores ranging between -1 and +1 were assigned to the no change category (these low change scores were considered random variations). Scores between -2 and -5 were categorized as moderate reduction, and scores of -6 to -9 were categorized as extreme reduction. The same classification algorithm applies to the plus sign referring to an increase in magnitude.

The statistical significance, direction and strength of linear correlation between 2 quantitative variables was measured by Spearman's rank linear correlation coefficient. P value less than the 0.05 level of significance was considered statistically significant using SPSS Version 24 (Chicago, IL, USA).

The results presented in this section were based on the analysis of an open invitation sample size of 500 adult registered patients who self-reported their answers and who resided in the UAE.

Among the study sample, approximately 28% had lost their taste and smell sensation during the active period of the disease. Regarding comorbid status, approximately 27.1% had chronic illnesses, and hypertension was the most common illness, followed by hyperlipidemia, respiratory illness, diabetes mellites, and allergies. Only one-third (34.2%) of the sample was 40 years of age and older. Females constituted approximately one-third (35.5%), and more than half of the sample were non-Arab Asians (53.2%). Smokers constituted slightly more than one-fifth (22%) of surveyed individuals. Approximately one-quarter (26.4%) of the study sample was asymptomatic, and another one-fifth (21.4%) was classified as paucisymptomatic with less severe symptoms (Table 1) .

The changes attributed to COVID-19 are listed in Table ( 2) as opposed to the predisease status. Only (16.2%) had lifted nasal block during COVID-19. However, 44% of the population studied had a reduction in the sense of smell, with most classified as an extreme reduction. The taste sensation was diminished in 43% of the studied population, an almost equal proportion to the percentage that experienced a reduction in smell sensation. Moreover, one-quarter (25%) had a decline in the ability to sense other stimuli in the mouth (such as burning, cooling, or tingling).

Young-age participants suffered from a drastic decrease in smell and taste senses (p<0.05), as seen in Tables 1 and 2 . However, there was no statistically significant positive linear association between age and improvements in the severity of smell and taste. Smell and taste changes were also not significantly different between males and females. There was a slightly greater decrease in smell and taste sensations among UAE nationals, while non-Arab Asians reported the lowest average decrease relative to other nationals. Smokers had a severe drop in both sensations when compared to nonsmokers (p<0.05). The magnitude of reduction in both sense changes increased steeply from the asymptomatic group to the paucisymptomatic group to the symptomatic group. The most severe form of the disease severity was associated with 58.2% and 53.3% of patients showing extreme reductions in smell and taste sensation, respectively.

Changes in the ability to feel other sensations in the mouth (such as burning, cooling, or tingling) attributed to COVID-19

The mean reduction in the ability to sense other sensations in the mouth (such as burning, cooling, or tingling) was slightly more severe at younger ages, as seen in Table ( 3). A statistically significant positive linear correlation was found between age and the change in the magnitude of these sensations. However, the changes were not significantly different between males and females. A significantly higher reduction in this type of sensation was seen in local UAE nationals, while non-Arab Asians and non-Arab Africans showed the lowest average reduction compared to other nationals. Smokers had a more extreme reduction in other mouth sensations than nonsmokers, but this association failed to reach a statistically significant level.

Additionally, the count of screened COVID-19 symptoms showed a statistically significant weak linear correlation with the magnitude of change in other mouth sensations during COVID-19 (r=-0.347). The magnitude of the reduction in taste increased steeply from the asymptomatic group to the paucisymptomatic group and reached its maximum in the symptomatic group. In the most severe form of the disease, 29.1% showed an extreme reduction in taste sensation.

As shown in Figure (1a) , approximately 61% of surveyed individuals stated that they were fully recovered, and 11.1% were partially recovered from major COVID-19 symptoms. A total of 26.7% of the studied sample was initially asymptomatic, as previously stated.

More than half (59%) of those who had suffered from a reduction in smell and taste sensation during COVID-19 fully gained back smell sensation two weeks after the recovery period, whereas one-third (26.9-30.7%) had a smell sense that recovered during the active disease period. Taste sensation recovery showed similar results (Figure 1c ).

According to Table (4), more than half of the recovered patients had improved smell and taste sensations (63.6% and 61.9%, respectively), while one-third (35.9%) had an increase in the ability to feel other sensations in the mouth (such as burning, cooling, or tingling) compared to the active duration of the disease. Approximately three-quarters of the recovered patients (75.1%) showed no change in nasal blockage after recovery compared to the active disease period, while less than one-quarter (13.4%) showed only a moderate reduction.

Over five months, a total of 32 published articles discussed the lack of sense of smell and taste in COVID-19 patients, all of which stated that olfactory dysfunction could occur at a very early stage of the disease prior to diagnosis confirmation by a PCR test. (7) Some studies have shown that males are more prone to loss of taste and smell sensation than females. (8) (9) (10) This study revealed no significant differences between the sexes, which agrees with Moein et al.'s study (11) . On the other hand, Lee et al. found that changes in taste and smell sensations were more dominant in females than in males. This study showed that young adults presented extreme declination in smell and taste sensations, with more significant declination shown in individuals in their late 30s. Similar results were presented by Lee et al., who found that more significant changes were recorded among the young population. (6) In the present study, approximately one-quarter of the studied population was smokers (22%), demonstrating a significantly higher percentage of taste and smell sensation changes (P=0.005). A study conducted in Qatar showed consistent results, where a significant correlation was seen between ageusia and anosmia among smokers. (10) In this study, most of the participants were symptomatic (52%) or paucisymptomatic (21.4%). Lee et al. showed that more than 84% of positive COVID-19 patients were asymptomatic or had moderate symptoms.(6) Identification of asymptomatic or paucisymptomatic patients is important, as isolating these patients will break the infection chain and restrict the spread of the disease. Symptomatic patients in this study reported more severe changes in smell and taste than paucisymptomatic and asymptomatic patients, but the severity of the symptoms was not studied. Mutiawati et a, in a systematic review and meta-analysis calculated the global prevalence of anosmia and dysgeusia in (COVID-19) patients, among which anosmia was prevalent by approximately 38.2%, whereas that of dysgeusia was 36.6%. Both of these symptoms were more common in COVID-19 compared to other respiratory infections (approximately 10 and 9 times, respectively). (13) In this study, nasal blockage, the ability to smell and taste, and the perception of other stimuli in the mouth, such as burning, cooling, or tingling, were examined. The results revealed that only 25% of the individuals showed a reduction in their ability to feel other mouth sensations. Parma et al. (14) reported that nearly 20% of COVID-19 patients had increased nasal obstruction but also stated that olfactory changes could not be attributed to nasal obstruction.

The results of the current study showed that slightly less than half of the COVID-19-positive patients (44%) had some degree of alteration in smell and taste sensations, while a higher percentage did not feel any changes in smell (55.6%) or taste (56%).

Other studies demonstrated changes in taste and smell sensation during COVID-19 infection relative to predisease status. However, the percentage and magnitude of these changes were reported differently in different studies. also reported that 51.4% of their studied population had a normal gustatory function, which is similar to the results of this study. (8) The outcome of this study showed that UAE nationals had a significantly higher reduction in smell and taste sensations, while non-Arab Asians showed the lowest average reduction in smell and taste sensation. Other Arabs and non-Arab Africans showed significant changes as well. Therefore, more studies are required to decide whether smell and taste dysfunction manifest in certain ethnicities more than in others.

In the current analysis, most patients recorded complete smell and taste improvement 2 weeks after recovery from COVID-19 symptoms. However, only a small percentage of patients did not recover from COVID-19 symptoms after testing negative.

The mean days of recovery from ageusia and anosmia were recorded by Al Ani and Acharya as almost one week, (10) Assessing smell and taste dysfunction through a phone call could limit the accuracy of the assessment, not only because its self-reported thus a subjective evaluation, but also in the context of a pandemic a questionnaire might lead to overestimation by the participants. Evaluation of the sensitivity, specificity, positive predictive value, and the negative predictive value in using the olfactory and gustatory dysfunction as a screening test should be determined in future studies, as well as the correlation of the severity of hyposmia and hypogeusia with the severity of symptoms.

Olfactory and gustatory disorders are prevalent symptoms in UAE COVID-19 patients who may not have nasal symptoms, particularly in the early stage of the disease.

Sudden anosmia or ageusia need to be recognized for early detection of COVID-19 infection to identify otherwise hidden carriers, thus favoring an early isolation strategy that will restrict the spread of the disease. 

Global Consortium for Chemosensory Research

Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study

Prevalence of taste and smell dysfunction in coronavirus disease 2019

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia

Prevalence and duration of acute loss of smell or taste in COVID-19 patients

Systematic Review and Meta-analysis of Smell and Taste Disorders in COVID-19

Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases

Evolution of Altered Sense of Smell or Taste in Patients with Mildly Symptomatic COVID-19

Prevalence of Anosmia and Ageusia in Patients with COVID-19 at a Primary Health Center

Smell dysfunction: a biomarker for COVID-19

COVID-19 and anosmia: A review based on up-to-date knowledge

Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms -a systematic review and meta-analysis

Extreme reduction (-9 to -6) 32 (9.0) Moderate reduction (-5 to -2) 48 (13.4)